These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3821846

  • 61. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL, Huang SC, Hung FC, Wang HS, Sun PC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(5):357-60. PubMed ID: 8942030
    [Abstract] [Full Text] [Related]

  • 62. Maple syrup urine disease: interrelations between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination.
    Treacy E, Clow CL, Reade TR, Chitayat D, Mamer OA, Scriver CR.
    J Inherit Metab Dis; 1992; 15(1):121-35. PubMed ID: 1583867
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68. CT and MRI in maple syrup urine disease.
    Uziel G, Savoiardo M, Nardocci N.
    Neurology; 1988 Mar; 38(3):486-8. PubMed ID: 3347354
    [Abstract] [Full Text] [Related]

  • 69. Lipid Nanoparticle mRNA Therapy Improves Survival and Reduces Serum Branched-Chain Amino Acids in Mouse Models of Maple Syrup Urine Disease.
    Greig JA, Jennis M, Dandekar A, Chorazeczewski JK, Param N, So M, Nayal M, Bell P, Coughlan K, Choi M, Giangrande PH, Martini PGV, Wilson JM.
    Hum Gene Ther; 2024 Sep; 35(17-18):726-733. PubMed ID: 39001827
    [No Abstract] [Full Text] [Related]

  • 70. MRI in acute intermittent maple syrup urine disease.
    Di Rocco M, Biancheri R, Rossi A, Allegri AE, Vecchi V, Tortori-Donati P.
    Neurology; 2004 Sep 28; 63(6):1078. PubMed ID: 15452301
    [No Abstract] [Full Text] [Related]

  • 71. How to detect maple-syrup urine disease in newborn infants.
    Fogelson MH.
    Clin Pediatr (Phila); 1970 Sep 28; 9(9):538. PubMed ID: 5465716
    [No Abstract] [Full Text] [Related]

  • 72. Maple syrup urine disease in mainland China.
    Ti WJ.
    J Pediatr Endocrinol Metab; 2011 Sep 28; 24(9-10):857. PubMed ID: 22145494
    [No Abstract] [Full Text] [Related]

  • 73. Pancreatitis in maple syrup urine disease -- a rare and easily overseen complication.
    Baertling F, Mayatepek E, Schlune A, Thimm E, Meißner T.
    Klin Padiatr; 2013 Mar 28; 225(2):88-89. PubMed ID: 23382018
    [No Abstract] [Full Text] [Related]

  • 74. Thiamin-responsive maple syrup urine disease: seizures after 7 years of satisfactory metabolic control.
    Delis D, Michelakakis H, Katsarou E, Bartsocas CS.
    J Inherit Metab Dis; 2001 Nov 28; 24(6):683-4. PubMed ID: 11768588
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. So-called thiamin-responsive maple syrup urine disease: 15-year follow-up of the original patient.
    Scriver CR, Clow CL, George H.
    J Pediatr; 1985 Nov 28; 107(5):763-5. PubMed ID: 4056978
    [No Abstract] [Full Text] [Related]

  • 79. False diagnosis of maple syrup urine disease owing to ingestion of herbal tea.
    Sewell AC, Mosandl A, Böhles H.
    N Engl J Med; 1999 Sep 02; 341(10):769. PubMed ID: 10475807
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.